- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
12 result(s) found for: Marburg virus disease.
Displaying page 1 of 1.
EudraCT Number: 2020-001732-10 | Sponsor Protocol Number: KKS-278 | Start Date*: 2020-05-28 |
Sponsor Name:Philipps-Universität Marburg | ||
Full Title: Ruxolitinib for treatment of Covid-19 induced lung injury ARDS (RuXoCoil) A single-arm, open-label, proof of concept study | ||
Medical condition: SARS-CoV-2 induced ARDS | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004674-94 | Sponsor Protocol Number: WI237607 | Start Date*: 2019-04-05 | |||||||||||
Sponsor Name:Riga Stradiņš University | |||||||||||||
Full Title: Open-label Phase IV Study to Investigate Broad-and Cross-neutralizing Antibodies after Primary Vaccination with Two Different TBE Vaccines | |||||||||||||
Medical condition: Active (prophylactic) immunization against tick-borne encephalitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001770-29 | Sponsor Protocol Number: KKS-256 | Start Date*: 2019-11-19 |
Sponsor Name:Philipps-Universität Marburg | ||
Full Title: Viral load guided Immunosuppression after Lung Transplantation An open-label, randomized, controlled, parallel-group, multicenter trial (VIGILung) | ||
Medical condition: Prophylaxis against lung transplant rejection Clinical experience suggests that individual tailoring of immunosuppression for patients after lung transplantation could potentially optimize patient ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003786-41 | Sponsor Protocol Number: V70P5 | Start Date*: 2007-10-22 |
Sponsor Name:Novartis Vaccines and Diagnostics S.r.l. | ||
Full Title: A Phase III, randomized, observer-blind, controlled, multi-center clinical study to evaluate the efficacy, safety and immunogenicity of one and two intramuscular doses of FLUAD versus control vacci... | ||
Medical condition: no medical, condition: healthy, | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) FI (Completed) IT (Completed) HU (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005173-23 | Sponsor Protocol Number: V49_23 | Start Date*: 2012-03-08 | |||||||||||||||||||||
Sponsor Name:Novartis Vaccines and Diagnostics GmbH | |||||||||||||||||||||||
Full Title: A Phase III, Multicenter, Observer-blind, Safety and Immunogenicity Study of Rabies Vaccine and Japanese Encephalitis Vaccine Administered Concomitantly and/or Separately According to 1 of 2 Differ... | |||||||||||||||||||||||
Medical condition: Safety and Immunogenicity of Rabies Vaccine and Japanese Encephalitis Vaccine administered concomitantly and/or separately according to 1 of 2 different pre-exposure prophylaxis schedules to health... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001676-21 | Sponsor Protocol Number: V48P7E1 | Start Date*: 2006-08-14 | |||||||||||
Sponsor Name:Novartis Vaccines and Diagnostics GmbH & Co. KG | |||||||||||||
Full Title: A phase IV, open-label, single-center study in adolescents and adults: Evaluation of immunogenicity and safety of the first booster immunization with Chiron’s TBE vaccine for adults in participants... | |||||||||||||
Medical condition: TBE prophylaxis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018371-18 | Sponsor Protocol Number: V44_14S | Start Date*: 2010-04-22 | |||||||||||
Sponsor Name:Novartis Vaccines and Diagnostics GmbH | |||||||||||||
Full Title: A Phase III, multicenter, uncontrolled, open-label study to evaluate safety and immunogenicity of Begrivac®, preservative free, inactivated split influenza vaccine, using the strain composition 201... | |||||||||||||
Medical condition: no medical condition, healthy volunteers will be recruited into the clinical trial for annual approval of influenza vaccine with the new strain composition according WHO and EMEA recommendation and... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002480-27 | Sponsor Protocol Number: V87P6 | Start Date*: 2007-08-15 | |||||||||||
Sponsor Name:Novartis Vaccines and Diagnostics GmbH & Co. KG | |||||||||||||
Full Title: A Phase II, Randomized, Controlled, Observer-blind, Single-center Study to Evaluate the Immunogenicity, Safety and Tolerability of Two Doses of FLUAD-H5N1 Influenza Vaccine in Subjects aged 6 month... | |||||||||||||
Medical condition: avian influenza | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019040-39 | Sponsor Protocol Number: V78_08S | Start Date*: 2010-04-28 | |||||||||||
Sponsor Name:Novartis Vaccines and Diagnostics GmbH | |||||||||||||
Full Title: A Phase III, multicenter, uncontrolled, open label study to evaluate safety and immunogenicity of FLUVIRIN® [Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur], Formulation 2010/2011, when ad... | |||||||||||||
Medical condition: Prophylaxis of influenza | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004139-29 | Sponsor Protocol Number: RETIC | Start Date*: 2011-12-06 | |||||||||||
Sponsor Name:Medizinische Universität Innsbruck / UK für Anästhesie und Intensivmedizin & UK für Allgem. u. Chirurg. Intensivmedizin | |||||||||||||
Full Title: RETIC trial: Reversal of Trauma Induced Coagulopathy by using Coagulation factor concentrates or Fresh frozen Plasma | |||||||||||||
Medical condition: Major trauma (Injury Severity Score, ISS >15), clinical signs/risk of blood loss and coagulopathy as measured by rotational thrombelastometry (ROTEM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000085-38 | Sponsor Protocol Number: V70_39S | Start Date*: 2012-03-08 | |||||||||||
Sponsor Name:NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. | |||||||||||||
Full Title: A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of FLUAD Surface Antigen, Inactivated, Adjuvanted with MF59C.1 Influenza Vaccine, Formulation 2012-201... | |||||||||||||
Medical condition: Clinical Trial on healthy volunteers (Active immunisation against influenza in the elderly (65 years of age and over), especially for those with an increased risk of associated complications (i.e. ... | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000063-24 | Sponsor Protocol Number: V71_32S | Start Date*: 2012-03-08 | |||||||||||
Sponsor Name:NOVARTIS VACCINES AND DIAGNOSTICS S.R.L. | |||||||||||||
Full Title: A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety & Immunogenicity of AGRIPPAL S1 Vaccine, Formulation 2012-2013, in Non-elderly Adult and Elderly Subjects | |||||||||||||
Medical condition: Clinical trial on healthy volunteers: prophylaxis of influenza, especially in subjects with a higher risk of flu associated complications. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
